(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) | |||||||||
(Address of Principal Executive Offices) | (Zip Code) |
Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||
SUPERNUS PHARMACEUTICALS, INC. | ||||||||
DATED: February 20, 2024 | By: | /s/ Timothy C. Dec | ||||||
Timothy C. Dec | ||||||||
Senior Vice President and Chief Financial Officer |
Cover Page |
Feb. 14, 2024 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Feb. 14, 2024 |
Entity Registrant Name | Supernus Pharmaceuticals, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity Filer Name | 001-35518 |
Entity Tax Identification Number | 20-2590184 |
Entity Address, Address Line One | 9715 Key West Ave |
Entity Address, City or Town | Rockville |
Entity Address, State or Province | MD |
Entity Address, Postal Zip Code | 20850 |
City Area Code | 301 |
Local Phone Number | 838-2500 |
Title of 12(b) Security | Common Stock, $0.001 par value per share |
Trading Symbol | SUPN |
Security Exchange Name | NASDAQ |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | false |
Amendment Flag | false |
Entity Central Index Key | 0001356576 |
\:KI6SE+ MB ="H3''JZOZ-A &,>+<][&>OIFZ5]>J^[.J'!!FN'.4;69A M[;)G8$TT?=I("],!KWKXJ'K8D3)AX@':6'MBX[MA6/I ;2PQH[SG;J&-V8"7 MHHV/BDPG])#?D-1-B:NSO3'DL.1FQ/1YTCM9&.1T@"(("W _X3 U+O 0:(,6P:ZYA'&PU&GHXFJ@KHMW3[ S?E_&H\*3:5W& M6[W)FIOR/;IXCW9^#3_SRIRME&?9]'WA'[4 _06'7R\=Z(DW.)ATYS,F<90J M;%VP@.)YLZ4/F]RBK_&V;H?0H8R"1"T/N>];*.GOT8QY,;UBQE P^L6@/OB2 M.@UNZ%0B"Q[](RS/<]:EH]B85$S+(: 43: 9M=0)EU/<)#,Q$/E8[TH&5IW)-;WC6?*@"[QT)) >DI:0J!Y@AQ MEJN0-M MBS]XL.4\)$L7R/?) &8G Q-W,,",[Y.>V37W M25M^A=]HF+-(8W8:K\]"#L+_#W !XWBI/[0$P]A5$F2L\WW*A=Q'MY/>]5U[ M/9K@S6@,U:J.8QWEW?2C?80ZAAADK7.(0*,^IX.!JF *-$WKEB^B\3S.A$&N MY.I#J6=T2DHIR289S'>9Q-!%IBPGOPKJL6 ?\#1/3?1:?X+B+H"$1^"4.]*@ M,/#%2\SW,R,[5X5^$J!^ -WZ0L[00 5T*S;_.P''H2 .^'AV0 ..?8['[O-P65OQ0>?=BH\OR>L>/(* MVURLFX;B7Y/,,,D-<];]53&\EP00Z=,$XVZ=OZ:6!*<90E@*Z@(-4?HQA2$; MT<#'U !Z0I)U@$L)8,X/4K!T42-(@'$>>;#F+MVK_J)@^6J:=6V/B%9L4S+ M?IP/,Y1,\$6/ ]G?(CCFAL=$+CCL8]VMWCYSMSTK^\:/>Z MEWUR\5NS=]9LM2\'G5;S SR3GUMY[7T54-?"7IV)5Q9,=&%D=:(,Y]\F&U:9#6\[SV9^UI:N9,"E]:7 M5HKIE_?UY_H;_P=02P,$% @ P9%46/\$X5AP @ ?0< !$ !S=7!N M+3(P,C0P,C$T+GAS9,U56T_;,!1^[Z_P\CSGWEM$BS00TJ1N0PPTWB8G.4DM M$CNS'5K^_6RW5@G0C4I[6%[BG/-]YWZ ,$)[-D@M-TEN!96I8X#J?QN RG MY7B9@4>3*9CG-K="LS6:RA)4BGQF2V ME0MOK527!<%FL_$WB<]%'<1A& 7W7U;?+=3;8QO*'@;H;2X:AT\"H\Z)! >7 M?<<&<"T P7KI%[P-3+IA'*4>(DH)FO<*KG1=+J$B?:,67L]^]:2A%852%[T! M4]8!X)E:$5^DI:D!TIX!U.ER.$3"UHVW&A$'N3NB]&-)_/@ZW)SD.[VJUX M090=B:/%L'ALCCB*<1+Y6UEZP;O<#@U1)A5A!9SB6W]AQ_L7,1PZ>UH,CG=Z M#-:8A,*O^6-0 C6=2]YV+X_!S0&;P] G88PKRS>2O:SK**OX3J!%)O#,17\# ME5N65QOPQHC85T9$(7CSEWD*.L'U="H*\OGV6 -K =7",SN$W=3^[ 3X.A(' M>>5@V *CUAY ZLVQ^:X."3D3ZJG3)J3N0P.[$OW/^3 M!2\)+TSU$LIO;&G/+UN\)^\A?R 6I"GZYG3>(:RCM+W057*_:<%PU7;?S];1 M"G8[OAS]!E!+ P04 " #!D518RZNV='<* !*7@ %0 '-U<&XM,C R M-# R,31?;&%B+GAM;-5<:V_;R!7]GE_!NE]:8"?B//@*$B]2;U($]29&[& 7 M+0IAGC81BC0H.K;_?8>49),6* OOKPR)Q?LA\ M&6?INQ/XVCUQ9,HS$:?7[TZ^77T$X O?T+ '_^X^NY\UO&[Q8R+9RS M7-)""N<^+FZ $@%Y&-V>;= M_(W$Q"<$88!#[ -"0@Q"(@1 ;H \X0;"\\@OUV\$T48N94#XT@,DDA)$'B2 MP\C%G&$_\%CE-(G3[V_*/XPNI:/#2Y?5TW W"9R\]I- M+E6[VR3/&UY+E%&)$OHERK]V#38; /] >(MMK < 5X7[^5 8=W'Z^6!PKW2& MD,<'7!MF,.35#?4A%6/=NT]##89^?,2'NBVR@B8CW!;/P]0@)^4+Y_K1>IC2 MT8YD6HVS3MTUJ/*AD*F0JVS9<.W$XMV)?C07,I[_D<>%-CS+%HN[-%YE[N4< MNJZKD.\"E^$0$(0HH#KS S?T&7=#J$L:G1=/-_5 \;WQ_ZLK:6&706^E/SU=?9CIJ_5!"!@#E M@TI2W1YG6Q_=^WR#D^9\#\MKBQG/]#SGM@ -PE6>+0P#*C+#3WU%G1[VQ,ER M(7,]>VT)H7'W74I^IUT^?GC@-_K3DY_U)SJ'2 O8A1% 'D6 ,*@ ]80/*"41 MHQ'U7.29:KAM@*E)>(/1V8!T2I3F$FXE<;^"AU)S9 %;LF(EX%VA]])OJ\/1 MY+LKG+IZ=]KU%R]$["HN$CE7D(2<110(Q"@@$NOBBQD$-/(]Y"OJ1Y#8"G?C M?&JBK4 YF7(@^AO[N[.!:Z_:)_;,%=N'DR.KU9:.7G)]&?<@J3XY&UVF+\-H MD^B6C;T\R^6,Y.(F2^7GNP63^3Q"2D642N![+@-$\ A$'I$ $QYQ%P ."9 P%]V'M- E M]5/*L_PVRZNF];*@A3S+[M(B?SS+A)PS[@5NQ!4@E.BFDR,(&(Q\H%M00E6( M4,B-%XX,QIN:0%>0G0;F7YP*M:;962-W2NCFZC7A?;^F#\SFD95^""*MTH % M/;V2@XG_T5*&1;#U1&)S6=_T\EX(?1\M*[]?\HL\^Q'K<.88!L1G$@+,. $$ M80A"%W&@)]N>4F'$_4#8Y97V@2::4-9@:PK8 +9-(QW\FN:/X:R-DSAZ$-8C M7>QF8T">Z' \ (0Q)XY"PQB#NK1&%*2J]DL=?Y: G#-,QZTC"^QCYQ;$YS/1U@ M^$VGI'GHBT"Y80!XN2U&E!\"&BH]G9!1*+V(!$(:9XO6$::6(IX.M:U0.AJF M4^(T3POM1.[/!8/I.7("L&;&2O0[H^^E]':/H\E[9T!U3>\VM!?R6?9#YN_9 MLL@I+^9AX!'7(Q'P>40!H;KF,Y\0P!@)?1P2C%UN*N"&YZD)MP+G_&<#[[_F M@FT2ME^HO6DXLD"-&; 29FNTO039]#2:$%L#J NPW:!O-_YA(?/K.+W^9Y[= M%S>Z6M_2]'$N/(P\CGT@"%& ,!&"* @Q$)11Z&, M#GK2(U +'43*U3D (Z)S@ B C)B$4ODBBHP/J70/,[44L-4W'J39'M1F_Y\T MV$?OK(_44T^AF[;KHP_305]F2 3W_4,/H]I,J R;3.4!IGT[JM>O3'Y;)[+FFU":RXQRG"NA]6GJ_;8Q\"YG$?!-@/ M7!2$7&+CFEQW/#5IGE4[/!J \/W*&^R)8%3?X=WU9W$^ 6NX>9FI"?+G9N@+K:+2]CKBT,FO:$0_E:YR&V)JJ_KO2K4P,WY-NNOTY M.]*MH77N1[=;]]]4NM*7SG4MY9 J 7SH>X H@@$MOZDO0QA!+XJ08,8'W>J. MIR;QIXV2$IS]OE'%E?EVD2T#8^T2[0R^U]90/=)!.T*5H]$W@NKPV_9_&N_W MK;1GVE%.DT^ZGWWXEWR ,,AH9%=D7XPP M-?&MB\8:I5/!=#1.V\+ZDDC3FCJ GG'*J3DS/>IH1_0#2NA+CR-7SXZ M@MG MEZ&]D-_K9"#*A/ QH==S-T(A58H"06D ".,*4!R% %*"L2#2Q=!XEMSP/#7A M/H%S2G3F S\ZE);UT92H"YY2\ ;/%F M6B?[L3%.B2RQ'?0;BUTA#ZB+-6 LK@1,A1X(<""PB@AD ;.3><=($Q6[1NLTX5K_GL!N@DUE M?P#:QA&_/6,]$L >-@:D@2[/(R>#/0%NIX1]%PRL_.M_YW$JX3P(E"2*Z/[7 MQPH0#G7MI\P#E"%*/*$8(OV^U%@?9:()X:FVK1\X)5CG2]IWTZA!K.4 ?,!MH"ZYP/M!KW%?Y7>1V7I['3HOI!.>5'/G,) M D($ 2 4ZXF 1 IPK#,!IQ&.F+33?'. B O-J_$JY\>/WWU/U!+ P04 M" #!D518,?@$':P& #J, %0 '-U<&XM,C R-# R,31?<')E+GAM;-6: M;6_;1A+'W^=3Z'QO;ZU]YJZ1N/"YR<&HVQB)BQ;W1MB'68DH10HK.K:__0UI MJXEK^TJ8 LP ABQ10\[L?W[:G1WR[0\WZVKV!?*V;.IW!^R0'LR@#DTLZ^6[ M@U\O/Q!S\,/QFS=O_T'([__^=#[[L0E7:ZC;V6D&UT*<79?M:M:N8/9;D_\H MO[C91>7:U.0U(]::?-YC:7RU4[XY3+G=GNVWP$0FHIN2#""$VD-((8&2/A MM. JTB(J)?^U/(H2C:CS)&I01%H 8A63)#!+1?!"%\KW%ZW*^H^C[L6[+ /6V__CN8-6VFZ/Y_/KZ^O#&Y^JPR ?SSV$%:T?*>MNZ.G0.MN71MC]XW@37]JK_;5RS9RVZ3V1G M1KI#A'$BV.'--AX ?_6_R;!% M:/KQGN.!^VMTWEX6"]RT4$>X&^/.2]6$!T95IW"3=V=6SD/5'UU$*!?]E4_\ MMLTNM M!0Q)2 6JG.@J9)RZF1&PL3/(B<>K]PZ%W86\Q[CXA6PB'R^;+'"^, MB>&B>]/I(GI-'KF[T^9E<>]^@9=HNZ#* .<\2KM)?4/W YB@$^?@9=K^ @'+1>(_!*HJZI,B)5U*0$ .H1"TK M=-P#(U\]#@)"31V(%RHXB>Q?NINSB%J5J;S;A-P/)%@(,29'/(:.11%N)RQH M($8H Y%[[9S8 PK/N!_$A9XZ%_O0=A*0G,2(*=C>_\-M&[!%X)HF&3UAAN$@ M++/$A*1)H8R3CC-MZ#[6DR=<#X*CF#H<8S6=$ABG^/9COFRNZX4.28J$;$>E M<0@Q,.($=20$)[V6%*S?Q[SQR/$@*,QW L4+]9P2$GU=]#%?Y.9+60=81!HL MQHO10RR(5((30P$(!1V%Y)Y2LX_2XFGO@^"PWPD<8Y2=$B$7S;9UU7_+35\V MXXJHDX]=V ":(K%M!2X)EH*E"B(3(F ZV%1C,+A6V_# )AP._/%TKURRKL; M']7%JJEWVR?.::# ) E?L)=S%$2OG+Z M/T.XRH@NX_ZR;"M _>AR6_@EW M+D=)^,KIO\RNN[G\^7;MFVKA#!>6"4<855CH&H<%#>>"1"8U)*V%4N/N7SUP M-RSQ$VY%OER\B?SHW]^$E:N7T/?:(W?**]SE0 JH L.9RR:4@EM(#K1*9N0= MK*>\#F-@PMW'T5*^,@J_8? MU*?->GU5W[?(M@N.12H+,1$=C>RZZ)IXTZE! MA0D<]SC6\E$L/.EV& P3;CF.%_.U)X:F*D/9XJ3V,VYP<^FJA8DNJN 9D50Y M(A%=E$%0+&VL\)2!ER#'30N/? [C8,+=Q9$ROC($%QDZ@J$.T#^?T3W:DS\F MC&,A%#AF;2!%[/8UJJ#$<\Z(EC0)1EEB8=R=[>=]#X-BPMW%/ 8FSX7]R<]VN<' ;5]\N"J=2X DW1X851&H>B*/6$,E-LH%I7!?W<9OB2>?# M'IR:?+]QO+"OS,<)$AX[RC]4;KF@,F!Q3"/NGG!IE-RA&+Y0)% )&JBEJ,8H M(AZX&\; A%N.+Q=O$K/"*4:>776&$]O-3W"[$,P)+),E*5($7 495D<*L66T M<)XEAW_C*LTGW0ZC8,+=Q_%B[HV&M_-'(I[C@>,W]U]T+]VC\<=O_@=02P$" M% ,4 " #!D518&!I[@^P- #P80 $0 @ $